rs377345813

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 8P and 16B. PVS1BP6_Very_StrongBS1BS2

The ENST00000381529.9(CSF2RA):​c.728_729insGTCGGTGAGACAGAAAG​(p.Tyr243ValfsTer16) variant causes a frameshift, stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00221 in 1,613,822 control chromosomes in the GnomAD database, including 70 homozygotes. There are 1,603 hemizygotes in GnomAD. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely benign (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.012 ( 33 hom., 831 hem., cov: 32)
Exomes 𝑓: 0.0012 ( 37 hom. 772 hem. )

Consequence

CSF2RA
ENST00000381529.9 frameshift, stop_gained

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.0960

Publications

0 publications found
Variant links:
Genes affected
CSF2RA (HGNC:2435): (colony stimulating factor 2 receptor subunit alpha) The protein encoded by this gene is the alpha subunit of the heterodimeric receptor for colony stimulating factor 2, a cytokine which controls the production, differentiation, and function of granulocytes and macrophages. The encoded protein is a member of the cytokine family of receptors. This gene is found in the pseudoautosomal region (PAR) of the X and Y chromosomes. Multiple transcript variants encoding different isoforms have been found for this gene, with some of the isoforms being membrane-bound and others being soluble. [provided by RefSeq, Jul 2008]
CSF2RA Gene-Disease associations (from GenCC):
  • surfactant metabolism dysfunction, pulmonary, 4
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • hereditary pulmonary alveolar proteinosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
BP6
Variant X-1294453-C-CACAGAAAGGTCGGTGAG is Benign according to our data. Variant chrX-1294453-C-CACAGAAAGGTCGGTGAG is described in ClinVar as [Likely_benign]. Clinvar id is 469626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0115 (1753/152266) while in subpopulation AFR AF = 0.0395 (1643/41548). AF 95% confidence interval is 0.038. There are 33 homozygotes in GnomAd4. There are 831 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 33 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CSF2RANM_172245.4 linkc.774_780+10dupCAGAAAGGTCGGTGAGA intron_variant Intron 8 of 12 ENST00000381529.9 NP_758448.1 P15509-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CSF2RAENST00000381529.9 linkc.728_729insGTCGGTGAGACAGAAAG p.Tyr243ValfsTer16 frameshift_variant, stop_gained Exon 8 of 13 1 NM_172245.4 ENSP00000370940.3 P15509-1

Frequencies

GnomAD3 genomes
AF:
0.0114
AC:
1735
AN:
152148
Hom.:
30
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0392
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00498
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.0115
GnomAD2 exomes
AF:
0.00313
AC:
785
AN:
251082
AF XY:
0.00217
show subpopulations
Gnomad AFR exome
AF:
0.0413
Gnomad AMR exome
AF:
0.00257
Gnomad ASJ exome
AF:
0.0000992
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000141
Gnomad OTH exome
AF:
0.000816
GnomAD4 exome
AF:
0.00124
AC:
1814
AN:
1461556
Hom.:
37
Cov.:
32
AF XY:
0.00106
AC XY:
772
AN XY:
727098
show subpopulations
African (AFR)
AF:
0.0424
AC:
1418
AN:
33462
American (AMR)
AF:
0.00277
AC:
124
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.0000812
AC:
7
AN:
86246
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53354
Middle Eastern (MID)
AF:
0.00418
AC:
24
AN:
5744
European-Non Finnish (NFE)
AF:
0.0000639
AC:
71
AN:
1111834
Other (OTH)
AF:
0.00280
AC:
169
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
98
197
295
394
492
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0115
AC:
1753
AN:
152266
Hom.:
33
Cov.:
32
AF XY:
0.0112
AC XY:
831
AN XY:
74436
show subpopulations
African (AFR)
AF:
0.0395
AC:
1643
AN:
41548
American (AMR)
AF:
0.00497
AC:
76
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68020
Other (OTH)
AF:
0.0114
AC:
24
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
81
162
244
325
406
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Nov 02, 2017
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

c.774_780+10dup in intron 9 of CSF2RA: This variant is not expected to have clin ical significance because it has been identified in 4.1% (976/24018) of African chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinsti tute.org; dbSNP rs770360117), including 19 homozygous individuals. ACMG/AMP Crit eria applied: BA1. -

May 05, 2018
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Surfactant metabolism dysfunction, pulmonary, 4 Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.096

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs377345813; hg19: chrX-1413346; COSMIC: COSV107442181; API